Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MAPK SIGNALING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MAPK SIGNALING |
| Key Genes/Proteins | AKT, AKT1, AMPK, APP, CASP3 |
| Related Diseases | AUTISM, cancer, CANCER, Cardiac |
| Related Pathways | Camp Signaling |
graph TD
MAPK_SIGNALING["MAPK SIGNALING"]
MAPK_SIGNALING -->|"regulates"| Hepatocyte_Apoptosis["Hepatocyte Apoptosis"]
MAPK_SIGNALING -->|"activates"| P38["P38"]
MAPK_SIGNALING -->|"regulates"| PI3K["PI3K"]
MAPK_SIGNALING -->|"inhibits"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
MAPK_SIGNALING -->|"activates"| NF_KB["NF-KB"]
KDEL["KDEL"] -->|"regulates"| MAPK_SIGNALING
Paeoniflorin["Paeoniflorin"] -->|"modulates"| MAPK_SIGNALING
ARHGEF2["ARHGEF2"] -->|"activates"| MAPK_SIGNALING
ATOX1["ATOX1"] -->|"activates"| MAPK_SIGNALING
lithium["lithium"] -->|"activates"| MAPK_SIGNALING
AKT["AKT"] -->|"regulates"| MAPK_SIGNALING
INFLAMMATION["INFLAMMATION"] -->|"activates"| MAPK_SIGNALING
APOPTOSIS["APOPTOSIS"] -->|"inhibits"| MAPK_SIGNALING| Target | Relation | Type | Str |
|---|---|---|---|
| PI3K-AKT-mTOR signaling | crosstalk_with | pathway | 0.90 |
| neural stem cells | active_in | cell_type | 0.90 |
| NF-kB signaling | crosstalk_with | pathway | 0.90 |
| Hepatocyte Apoptosis | regulates | process | 0.89 |
| Prostate Cancer Progression | contributes_to | process | 0.85 |
| microglia | active_in | cell_type | 0.80 |
| neurons | active_in | cell_type | 0.80 |
| astrocytes | active_in | cell_type | 0.70 |
| pyroptosis | mediates | process | 0.70 |
| unfolded protein response | crosstalk_with | pathway | 0.70 |
| P38 | activates | gene | 0.65 |
| endothelial cells | active_in | cell_type | 0.60 |
| white matter | active_in | brain_region | 0.60 |
| calcium signaling | crosstalk_with | pathway | 0.60 |
| cortex | active_in | brain_region | 0.60 |
| ER stress | mediates | process | 0.60 |
| protein misfolding | mediates | process | 0.60 |
| ferroptosis | mediates | process | 0.60 |
| tau phosphorylation | mediates | process | 0.60 |
| synaptic plasticity | crosstalk_with | pathway | 0.60 |
| glymphatic clearance | crosstalk_with | pathway | 0.60 |
| ferroptosis | crosstalk_with | pathway | 0.60 |
| autophagy pathway | crosstalk_with | pathway | 0.60 |
| necroptosis | crosstalk_with | pathway | 0.60 |
| calcium signaling | mediates | process | 0.60 |
| nucleus accumbens | active_in | brain_region | 0.60 |
| dendritic cells | active_in | cell_type | 0.60 |
| pyroptosis | crosstalk_with | pathway | 0.60 |
| spinal cord | active_in | brain_region | 0.60 |
| BERBERINE | activates | concept | 0.50 |
| NF-KB | activates | gene | 0.50 |
| NF-KB | inhibits | gene | 0.50 |
| NEUROINFLAMMATION | inhibits | process | 0.50 |
| PI3K | regulates | gene | 0.50 |
| PI3K | therapeutic_target | gene | 0.35 |
| PYROPTOSIS | inhibits | process | 0.35 |
| RAS | activates | gene | 0.35 |
| TNF | regulates | gene | 0.35 |
| TNF | inhibits | gene | 0.35 |
| TLR4 | inhibits | gene | 0.35 |
| NEUTROPHILS | therapeutic_target | cell_type | 0.35 |
| SPINAL CORD INJURY | inhibits | disease | 0.35 |
| P38 | regulates | gene | 0.35 |
| TOLL-LIKE RECEPTOR SIGNALING | regulates | process | 0.35 |
| RAS | inhibits | gene | 0.35 |
| PI3K | protects_against | gene | 0.35 |
| NEURODEGENERATION | activates | process | 0.35 |
| TNF | activates | gene | 0.35 |
| OXIDATIVE STRESS | activates | process | 0.35 |
| P38 | inhibits | gene | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| KDEL | regulates | receptor | 0.92 |
| Paeoniflorin | modulates | compound | 0.91 |
| MAPK | participates_in | gene | 0.90 |
| JNK | participates_in | gene | 0.90 |
| PI3K-AKT-mTOR Pathway | interacts_with | pathway | 0.90 |
| ERK | participates_in | gene | 0.90 |
| neuroinflammation | involves | disease | 0.90 |
| Donepezil | inhibits | drug | 0.90 |
| NLRP3 | participates_in | gene | 0.90 |
| PI3K | participates_in | gene | 0.90 |
| neurodegeneration | involves | disease | 0.90 |
| GSK3 | participates_in | gene | 0.80 |
| TNF | participates_in | gene | 0.80 |
| Alzheimer's disease | involves | disease | 0.80 |
| ERK1 | participates_in | gene | 0.80 |
| MAPK14 | participates_in | gene | 0.80 |
| ALS | participates_in | gene | 0.80 |
| AKT | participates_in | gene | 0.80 |
| MAP | participates_in | gene | 0.80 |
| ATOX1 | activates | gene | 0.80 |
| JAK | participates_in | gene | 0.80 |
| MEK | participates_in | gene | 0.80 |
| PIK3CA | participates_in | gene | 0.80 |
| lithium | activates | drug | 0.80 |
| ESR1 | participates_in | gene | 0.80 |
| MAPK3 | participates_in | gene | 0.80 |
| ERN1 | participates_in | gene | 0.80 |
| AMPK | participates_in | gene | 0.80 |
| GSK3B | participates_in | gene | 0.80 |
| ATG | participates_in | gene | 0.80 |
| SNCA | participates_in | gene | 0.80 |
| BECN1 | participates_in | gene | 0.80 |
| ARHGEF2 | activates | gene | 0.80 |
| NLR | participates_in | gene | 0.80 |
| neurons | active_in | cell_type | 0.75 |
| microglia | active_in | cell_type | 0.75 |
| RIPK3 | participates_in | gene | 0.70 |
| CALCOCO2 | participates_in | gene | 0.70 |
| BCL2 | participates_in | gene | 0.70 |
| HIF | participates_in | gene | 0.70 |
| TREM2 | participates_in | gene | 0.70 |
| NFE2L2 | participates_in | gene | 0.70 |
| CNR1 | participates_in | gene | 0.70 |
| FIP200 | participates_in | gene | 0.70 |
| VEGFA | participates_in | gene | 0.70 |
| ATP | participates_in | gene | 0.70 |
| SOD1 | participates_in | gene | 0.70 |
| LRP1 | participates_in | gene | 0.70 |
| PTEN | participates_in | gene | 0.70 |
| AMBRA1 | participates_in | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MAPK SIGNALING in their description or question text
No additional research found